Mainz Biomed - 53 Year Dividend History | MYNZ
Historical dividend payout and yield for Mainz Biomed (MYNZ) since 1971. The current TTM dividend payout for Mainz Biomed (MYNZ) as of November 01, 2024 is $0.00. The current dividend yield for Mainz Biomed as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.001B |
|
Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
